Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SMS PHARMA Gains 13%; BSE HEALTHCARE Index Up 0.8%
Wed, 11 Sep 9:55

SMS PHARMA Gains 13%; BSE HEALTHCARE Index Up 0.8%Image source: Sakorn BernardaSv/www.istockphoto.com

SMS PHARMA share price has zoomed 13% and is presently trading at Rs 381.3.

Meanwhile, the BSE HEALTHCARE index is at 44,174.7 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.5%) and Procter & Gamble Health (up 2.4%).

SYNGENE INTERNATIONAL (down 1.2%) and ERIS LIFESCIENCES (down 1.0%) are among the top losers today.

Over the last one year, SMS PHARMA has moved up from Rs 127.2 to Rs 381.3, registering a gain of Rs 254.2 (up 199.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,174.7, registering a gain of 55.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 134.5%), Jubilant Pharmova (up 129.2%) and GRANULES INDIA (up 121.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,978.9 (up 0.1%).

The top gainers among the BSE Sensex today are Asian Paints (up 0.8%) and Bajaj Finance (up 0.8%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 25,062.1 (up 0.1%). Bajaj Auto and Dr. Reddys are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 81,978.9, registering a gain of 14,851.9 points (up 22.1%).

SMS PHARMA Financial Update...

SMS PHARMA net profit grew 85.9% YoY to Rs 164 million for the quarter ended June 2024, compared to a profit of Rs 88 million a year ago. Net sales rose 21.5% to Rs 1,645 million during the period as against Rs 1,353 million in April-June 2023.

For the year ended March 2023, SMS PHARMA reported 94.3% decrease in net profit to Rs 39 million compared to net profit of Rs 679 million during FY22. Revenue of the company grew 1.2% to Rs 4,914 million during FY23.

The current Price to earnings ratio of SMS PHARMA, based on rolling 12 month earnings, stands at 56.9.


Equitymaster requests your view! Post a comment on "SMS PHARMA Gains 13%; BSE HEALTHCARE Index Up 0.8%". Click here!